Profile of changes in bone turnover markers during once-weekly teriparatide administration for 24 weeks in postmenopausal women with osteoporosis

number of downloads : ?

Use this link to cite this item : https://ir.lib.shimane-u.ac.jp/53740

language	eng
Author	Sugimoto, Toshitsugu Nakamura T. National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan View autho Nakamura Y. Project for Bone Metabolic Disease, Asahi Kasei Pharma Corporation, 1-105 Kanda Jinbocho, Chiyoda-ku, Tokyo, 101-8101, Japan Isogai Y. Project for Bone Metabolic Disease, Asahi Kasei Pharma Corporation, 1-105 Kanda Jinbocho, Chiyoda-ku, Tokyo, 101-8101, Japan Shiraki M. Research Institute and Practice for Involutional Diseases, 1610-1 Meisei, Misato, Azumino, Nagano, 399-8101, Japan
Subject	Bone formation; Bone resorption; Calcium metabolism; Human; Teriparatide
Journal Title	OSTEOPOROSIS INTERNATIONAL
Volume	25
Issue	3
Start Page	1173
End Page	1180
ISSN	0937-941X
ISSN（Online）	1433-2965
Published Date	2014-03
DOI	10.1007/s00198-013-2516-1
PubMed ID	24108429
Publisher	SPRINGER LONDON LTD
NII Type	Journal Article
OAI-PMH Set	Faculty of Medicine
Remark	Asahi Kasei Pharma Corporation provided funding and supplied the test drugs for this study.